SAMI Pharmaceuticals
SAMI Pharmaceuticals (Pvt.) Ltd. is a privately held Pakistani generic pharmaceutical manufacturer, founded in 1971 and headquartered in Karachi. It produces and distributes medicines across analgesics, anti-infectives, supplements, gastrointestinal, and other therapeutic categories for patients throughout Pakistan.
- Company typePrivate
- Founded1971
- HeadquartersKarachi, Pakistan
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
SAMI Pharmaceuticals firmographics
Firmographics- Name
- SAMI Pharmaceuticals
- Legal name
- SAMI Pharmaceuticals (Pvt.) Ltd.
- Website
- https://samipharmapk.com
- Company type
- Private
- Founded year
- 1971
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- SAMI Pharmaceuticals (Pvt.) Ltd. is a privately held Pakistani generic pharmaceutical manufacturer, founded in 1971 and headquartered in Karachi. It produces and distributes medicines across analgesics, anti-infectives, supplements, gastrointestinal, and other therapeutic categories for patients throughout Pakistan.
- Ownership category
- akta.pro rank
Where SAMI Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Karachi
- HQ country
- Pakistan
- HQ region
- Asia
Offices2 records
Markets served
SAMI Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Distribution channels1 record
Marketing channels1 record
SAMI Pharmaceuticals product offering
Product offeringCore offering
SAMI Pharmaceuticals (Pvt.) Ltd. is a Pakistan-based pharmaceutical manufacturer that produces and sells a portfolio of generic medicines across multiple therapeutic categories, including analgesics, anti-infectives, supplements, gastrointestinal drugs, and other therapeutic areas. The company operates its own manufacturing plant in Karachi's S.I.T.E. industrial area and distributes products through a domestic distribution network to serve patients across all socioeconomic classes in Pakistan.
Product overview
SAMI Pharmaceuticals (Pvt.) Ltd. is a pharmaceutical company offering a portfolio of quality generic medicines across multiple therapeutic categories. The company's product portfolio includes ANALGESICS, ANTI-INFECTIVES, SUPPLEMENTS, GASTROINTESTINAL DRUGS, and OTHER therapeutic areas. Key products include DENORIN (Enoxaparin Sodium injection), NADEE (Nadifloxacin cream), and Novidat Suspension (antibiotic) which has undergone rebranding.
Differentiator
Problem solved
Functional benefit
Products and services
- DENORIN (Enoxaparin Sodium) Enoxaparin Sodium injection product introduced by SAMI Pharmaceuticals for the Pakistan market as an anticoagulant therapeutic offering.
- NADEE (Nadifloxacin) Nadifloxacin cream product introduced by SAMI Pharmaceuticals for the Pakistan market as a topical anti-infective therapeutic offering.
- Novidat Suspension 250mg Antibiotic suspension product (250mg) in SAMI Pharmaceuticals' portfolio, part of the anti-infectives therapeutic category.
- Novidat Suspension 125mg Antibiotic suspension product (125mg) in SAMI Pharmaceuticals' portfolio, part of the anti-infectives therapeutic category.
Companies that use SAMI Pharmaceuticals
Customer profileSegments1 record
Ideal customer profiles1 record
SAMI Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
SAMI Pharmaceuticals partnerships and signals
Strategic signalRecent moves4 records
Expansion highlights4 records
SAMI Pharmaceuticals competitors and assessment
Company assessmentDirect peers
- The Searle Company Limited: Established Karachi-headquartered pharma manufacturer with a wide therapeutic portfolio across anti-infectives, analgesics, and gastrointestinals. Direct comparable to SAMI on geographic focus, manufacturing footprint, and product categories served.
- Ferozsons Laboratories: Long-standing Pakistani pharmaceutical manufacturer with branded generics, in-licensed brands, and Hepatitis B vaccine partnerships. Comparable to SAMI in domestic manufacturing scale, therapeutic breadth, and B2B distribution model.
- Getz Pharma: One of Pakistan's largest private pharmaceutical manufacturers with broad therapeutic coverage across anti-infectives, cardiovascular, and consumer health. Highly comparable to SAMI on customer base (Pakistani patients and physicians), manufacturing model, and product mix in branded generics.
- Highnoon Laboratories: Pakistan-focused pharma company with manufacturing and a portfolio spanning anti-infectives, cardiovascular, and supplements. Similar to SAMI in size, therapeutic scope, and reliance on domestic distribution channels.
- PharmEvo Private Limited: Karachi-based pharmaceutical company manufacturing branded generics across cardiovascular, anti-infectives, and gastrointestinals. Comparable to SAMI on therapeutic portfolio overlap, manufacturing model, and Pakistan-only geographic focus.
- Bosch Pharmaceuticals: Karachi-headquartered pharma manufacturer with strong anti-infective and antibiotic focus overlapping with SAMI's Novidat franchise. Comparable on manufacturing scale, geographic concentration in Pakistan, and product positioning in branded generics.
- Wilshire Laboratories: Pakistani pharmaceutical manufacturer focused on branded generics across multiple therapeutic classes. Comparable to SAMI as a mid-sized domestic manufacturer competing for the same physician and patient base.
- AGP Limited (Associated Group of Pharmaceuticals): Karachi-based pharmaceutical manufacturer with own formulation plant and broad therapeutic lineup including anti-infectives, GI, and analgesics. Direct comparable on manufacturing model, Pakistan market focus, and product overlap with SAMI's therapeutic categories.
Broad incumbents
- Abbott Laboratories Pakistan: Subsidiary of global Abbott operating a broader portfolio spanning nutrition, diagnostics, and pharmaceuticals in Pakistan. Serves as a multinational incumbent competing against domestic manufacturers like SAMI in many of the same therapeutic categories.
- GlaxoSmithKline Pakistan: Multinational pharma subsidiary with established consumer health and prescription brands across anti-infectives and wellness. Operates as a major branded competitor to SAMI in Pakistan across overlapping therapeutic areas.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
SAMI Pharmaceuticals social profiles
Digital presenceSAMI Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
SAMI Pharmaceuticals leadership team
Management profileNumber of profiles
SAMI Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SAMI Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SAMI Pharmaceuticals
What does SAMI Pharmaceuticals do?
SAMI Pharmaceuticals (Pvt.) Ltd. is a Pakistan-based pharmaceutical manufacturer that produces and sells a portfolio of generic medicines across multiple therapeutic categories, including analgesics, anti-infectives, supplements, gastrointestinal drugs, and other therapeutic areas. The company operates its own manufacturing plant in Karachi's S.I.T.E. industrial area and distributes products through a domestic distribution network to serve patients across all socioeconomic classes in Pakistan.
Is SAMI Pharmaceuticals a public or private company?
SAMI Pharmaceuticals is a private company. It is classified as unknown and is currently operating.
When was SAMI Pharmaceuticals founded?
SAMI Pharmaceuticals was founded in 1971. It employs 1,001 to 5,000 people.
Where is SAMI Pharmaceuticals based?
SAMI Pharmaceuticals is headquartered in Karachi, Pakistan, in the Asia region.
Who are SAMI Pharmaceuticals's main competitors?
Direct peers on record are The Searle Company Limited, Ferozsons Laboratories, Getz Pharma, Highnoon Laboratories, PharmEvo Private Limited, Bosch Pharmaceuticals, Wilshire Laboratories and AGP Limited (Associated Group of Pharmaceuticals). Broad incumbents are Abbott Laboratories Pakistan and GlaxoSmithKline Pakistan.
Does SAMI Pharmaceuticals have an API?
No public API is recorded for SAMI Pharmaceuticals.